SYB-509

N/A

Report date: 2023/01/07 18:45:00

Base Information

Drug NameSYB-509
Drug Alias NameSYB-509注射液（四川远大蜀阳）SYB-509
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionVascular endothelial growth factor A stimulants
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsCarcinoma, Transitional CellCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional CellCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A